QQQ   270.30 (-0.43%)
AAPL   450.68 (+1.40%)
MSFT   206.97 (-2.59%)
FB   262.37 (-2.26%)
GOOGL   1,491.06 (-0.49%)
AMZN   3,133.00 (-1.09%)
NVDA   448.33 (+0.08%)
CGC   18.01 (+8.30%)
BABA   248.46 (-1.44%)
TSLA   1,419.95 (-2.26%)
MU   49.34 (+1.21%)
GE   6.67 (+4.06%)
AMD   82.49 (-2.78%)
T   30.18 (+0.53%)
F   7.06 (+2.92%)
ACB   10.32 (+0.49%)
GILD   68.33 (-1.47%)
NFLX   483.64 (-2.24%)
DIS   128.75 (-0.92%)
BAC   26.52 (+1.57%)
BA   179.21 (+5.41%)
QQQ   270.30 (-0.43%)
AAPL   450.68 (+1.40%)
MSFT   206.97 (-2.59%)
FB   262.37 (-2.26%)
GOOGL   1,491.06 (-0.49%)
AMZN   3,133.00 (-1.09%)
NVDA   448.33 (+0.08%)
CGC   18.01 (+8.30%)
BABA   248.46 (-1.44%)
TSLA   1,419.95 (-2.26%)
MU   49.34 (+1.21%)
GE   6.67 (+4.06%)
AMD   82.49 (-2.78%)
T   30.18 (+0.53%)
F   7.06 (+2.92%)
ACB   10.32 (+0.49%)
GILD   68.33 (-1.47%)
NFLX   483.64 (-2.24%)
DIS   128.75 (-0.92%)
BAC   26.52 (+1.57%)
BA   179.21 (+5.41%)
QQQ   270.30 (-0.43%)
AAPL   450.68 (+1.40%)
MSFT   206.97 (-2.59%)
FB   262.37 (-2.26%)
GOOGL   1,491.06 (-0.49%)
AMZN   3,133.00 (-1.09%)
NVDA   448.33 (+0.08%)
CGC   18.01 (+8.30%)
BABA   248.46 (-1.44%)
TSLA   1,419.95 (-2.26%)
MU   49.34 (+1.21%)
GE   6.67 (+4.06%)
AMD   82.49 (-2.78%)
T   30.18 (+0.53%)
F   7.06 (+2.92%)
ACB   10.32 (+0.49%)
GILD   68.33 (-1.47%)
NFLX   483.64 (-2.24%)
DIS   128.75 (-0.92%)
BAC   26.52 (+1.57%)
BA   179.21 (+5.41%)
QQQ   270.30 (-0.43%)
AAPL   450.68 (+1.40%)
MSFT   206.97 (-2.59%)
FB   262.37 (-2.26%)
GOOGL   1,491.06 (-0.49%)
AMZN   3,133.00 (-1.09%)
NVDA   448.33 (+0.08%)
CGC   18.01 (+8.30%)
BABA   248.46 (-1.44%)
TSLA   1,419.95 (-2.26%)
MU   49.34 (+1.21%)
GE   6.67 (+4.06%)
AMD   82.49 (-2.78%)
T   30.18 (+0.53%)
F   7.06 (+2.92%)
ACB   10.32 (+0.49%)
GILD   68.33 (-1.47%)
NFLX   483.64 (-2.24%)
DIS   128.75 (-0.92%)
BAC   26.52 (+1.57%)
BA   179.21 (+5.41%)
Log in

NASDAQ:CCXIChemoCentryx SEC Filings & 10K Form

$56.33
+1.09 (+1.97 %)
(As of 08/10/2020 03:19 PM ET)
Add
Compare
Today's Range
$54.80
Now: $56.33
$57.12
50-Day Range
$52.20
MA: $56.28
$61.69
52-Week Range
$6.37
Now: $56.33
$65.43
Volume7,025 shs
Average Volume558,842 shs
Market Capitalization$3.48 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.94

SEC Filings

ChemoCentryx (NASDAQ:CCXI) SEC Filings

DateFilerForm TypeView
08/03/2020
6:10 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
6:55 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2020
6:53 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
5:32 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2020
7:00 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2020
6:56 AM
ChemoCentryx (Subject)
Vifor Ltd (0001675217) (Filed by)
Form SC 13D/A
07/13/2020
6:18 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2020
7:39 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2020
5:57 PM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
7:20 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
7:08 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
7:02 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
4:24 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2020
4:22 PM
ChemoCentryx (Filer)
Form 424B5
06/10/2020
4:01 PM
ChemoCentryx (Filer)
Form 424B5
06/05/2020
6:11 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
8:04 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:59 PM
ChemoCentryx (Issuer)
Tyree James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:55 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:49 PM
ChemoCentryx (Issuer)
MCKINNELL HENRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:45 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:39 PM
ChemoCentryx (Issuer)
FECZKO JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:34 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:31 AM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2020
3:45 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
6:50 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
6:45 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:44 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
3:26 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
7:11 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
6:59 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
7:19 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2020
3:30 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
3:16 PM
ChemoCentryx (Filer)
Form DEF 14A
03/31/2020
7:07 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2020
6:10 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2020
5:42 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
6:03 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
5:55 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
5:48 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
6:24 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
6:15 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
6:05 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
2:09 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ChemoCentryx (Subject)
Form SC 13G/A
02/13/2020
7:00 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
6:50 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
6:53 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2020
5:51 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
7:32 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
7:12 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/05/2020
7:02 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:31 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
6:55 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
6:49 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
6:42 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
6:36 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
7:00 AM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2020
5:29 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
5:23 PM
ChemoCentryx (Issuer)
Tyree James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
6:02 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:10 PM
ChemoCentryx (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G
01/10/2020
12:59 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
6:35 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
4:37 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
4:27 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
6:14 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
6:34 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
5:10 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
6:34 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
6:18 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
6:11 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
3:15 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
5:50 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:28 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
3:17 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
5:29 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
3:19 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2019
3:16 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
5:17 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:01 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
8:20 PM
ChemoCentryx (Issuer)
Tyree James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
8:10 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:58 PM
ChemoCentryx (Issuer)
FECZKO JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:53 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:49 PM
ChemoCentryx (Issuer)
MCKINNELL HENRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:42 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2019
11:15 PM
ChemoCentryx (Filer)
Form EFFECT
05/10/2019
12:40 PM
BlackRock Inc. (Filed by)
ChemoCentryx (Subject)
Form SC 13G/A
05/07/2019
2:45 PM
ChemoCentryx (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/06/2019
3:19 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
3:16 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
5:46 PM
ChemoCentryx (Issuer)
SINGH RAJINDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2019
4:00 PM
BIO-TECHNE Corp (Filed by)
ChemoCentryx (Subject)
Form SC 13G/A
04/10/2019
9:34 AM
ChemoCentryx (Subject)
FMR LLC (Filed by)
Form SC 13G
04/08/2019
3:02 PM
ChemoCentryx (Filer)
Form DEF 14A
04/02/2019
6:49 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
7:08 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
7:02 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
6:46 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2019
12:17 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.